studio.mjhassoc.com - OncLive® will be LIVE with OncLive® News Network: On Location at the virtual 2021 ASCO GI. Each day, we will broadcast a series of...
Tweets from: OncLive
Pembrolizumab/Capecitabine/Bevacizumab Demonstrates Encouraging Tolerability MSS mCRC
posted 2 days
Mashup Score: 3
OncLive - January 15, 2021 – The combination use of pembrolizumab with capecitabine and bevacizumab was suggested to be tolerable in patients with microsatellite stable metastatic...
Nivolumab Improves Quality of Life in Patients with Esophageal/Gastroesophageal Cancer
posted 2 days
Mashup Score: 2
OncLive - January 15, 2021 – Patients with esophageal/gastroesophageal cancer treated with nivolumab had improved esophageal-specific and general quality of life, although trends were similar in...
Pembrolizumab Triplet Appears Effective in HER2+ Advanced Gastric, GEJ Cancer Regardless of PD-L1 Status
posted 2 days
Mashup Score: 2
OncLive - January 15, 2021 – Pembrolizumab with trastuzumab and the combination of cisplatin and capecitabine appeared effective in treating HER2-positive advanced gastric and gastroesophageal junction...
Adjuvant S-1/Docetaxel Combo Shows Survival Improvement in Stage III Gastric Cancer
posted 1 day
Mashup Score: 2
OncLive - January 15, 2021 – Combination treatment with adjuvant S-1 and docetaxel led to an estimated 29% reduction in the risk of relapse compared with...
OncLive - A novel artificial intelligence-based search tool made it easier for patients to find and understand cancer clinical trials, while also offering more clarity on...
Mean Daily Step Count While Receiving SM-88 Correlated With Patient-Reported QoL in Metastatic Pancreatic Cancer
posted 14 hours
Mashup Score: 2
OncLive - January 16, 2021 – Mean daily step count during the first 2 weeks of treatment with SM-88 was found to correlate with overall self-reported...
Camrelizumab/Apatinib Shows Promising Activity in Second-Line Esophageal Squamous Cell Carcinoma
posted 2 days
Mashup Score: 1
OncLive - January 15, 2021 – A novel combination comprised of camrelizumab and apatinib was found to have promising clinical efficacy with an acceptable safety profile...
OncLive - January 16, 2021 – Lenvatinib monotherapy was found to be effective in patients with unresectable hepatocellular carcinoma in the United...
OncLive - The field of HER2-positive gastrointestinal malignancies witnessed a surge of data in 2020 regarding investigational agents, such as the antibody-drug conjugate fam-trastuzumab deruxtecan-nxki, that...
Tune in to tonight's episode of #OncLiveOnLocation hosted by @ginacolumbusonc. Get the latest updates from the @ASCO 2021 #GI Cancers Symposium and hear insights from @GIcancerDoc of @MayoClinic & Elizabeta C. Popa, MD of @WeillCornell. Register here: https://t.co/JQM2IB9CuG https://t.co/JQM2IB9CuG